NCT01092052View on ClinicalTrials.gov

Study of NMS-1116354 in Advanced/Metastatic Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2012

Conditions
Advanced/Metastatic Solid Tumors
Interventions
DRUG

NMS-1116354

Oral daily administration for 14 consecutive days followed by 7 days of rest

Trial Locations (1)

Unknown

Institut Gustave-Roussy (IGR), Villejuif

Sponsors
All Listed Sponsors
lead

Nerviano Medical Sciences

INDUSTRY

NCT01092052 - Study of NMS-1116354 in Advanced/Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter